Immunotech Biopharm Ltd (HKG:6978)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
0.7400
-0.0500 (-6.33%)
May 28, 2026, 4:08 PM HKT
Market Cap456.95M -77.2%
Revenue (ttm)n/a
Net Income-256.82M
EPS-0.47
Shares Out 617.50M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume463,000
Open0.7700
Previous Close0.7900
Day's Range0.7300 - 0.7900
52-Week Range0.7300 - 5.8300
Beta0.17
Analystsn/a
Price Targetn/a
Earnings DateMar 20, 2026

About Immunotech Biopharm

Immunotech Biopharm Ltd, a cellular immunotherapy biopharmaceutical company, focuses on the research, development, and commercialization of T cell immunotherapy products for the treatment of cancers in the People’s Republic of China. The company’s core product is EAL, a multi-target cellular immunotherapy product that has completed Phase III clinical trials for the prevention of postsurgical recurrence of liver cancer. It also develops CAR-T-19 injection product for B-cell acute lymphoblastic leukaemia that is in Phase II/III clinical trial; 6B... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2006
Employees 183
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 6978
Full Company Profile

Financial Performance

Financial numbers in CNY Financial Statements